ClinicalTrials.gov
ClinicalTrials.gov Menu

Short Message System (SMS) Monitoring Intended for the Suicidal Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02106949
Recruitment Status : Active, not recruiting
First Posted : April 8, 2014
Last Update Posted : March 19, 2018
Sponsor:
Collaborator:
Technopôle Brest-Iroise: LANESTEL SARL, 38 rue Jim Sevellec, 29200 Brest
Information provided by (Responsible Party):
University Hospital, Brest

Brief Summary:
The study wants to prove that SMS monitoring reduced the number of suicide attempts in six months according to the beginning of its implementation in the group of the patients benefiting SMS compared with the group of patients benefiting from the usual care.

Condition or disease Intervention/treatment Phase
Patients Having Realized a Suicide Attempt Device: SMS contact with patient after discharge in intervention group Phase 3

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 530 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Short Message System (SMS) Monitoring Intended for the Suicidal Patients: Study of Efficiency
Study Start Date : August 2014
Estimated Primary Completion Date : May 2019
Estimated Study Completion Date : August 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Suicide
U.S. FDA Resources

Arm Intervention/treatment
Experimental: SMS
The patients of the test group receive a first SMS 48 hours after their discharge from the hospital then a total of 10 messages distributed over six months: 48 hours, S1, S2, M1, M2, M3, M4, M5, M6 and M13.
Device: SMS contact with patient after discharge in intervention group
No Intervention: Without SMS
The patients of the group benefit from the usual care.



Primary Outcome Measures :
  1. Number of suicide reattempts in every group [ Time Frame: 6 months ]

Secondary Outcome Measures :
  1. Number of suicide reattempts in every group [ Time Frame: 13 months ]
  2. Total number of suicidal second recurrences in every group [ Time Frame: 6 months ]
  3. Total number of suicidal second recurrences in every group [ Time Frame: 13 months ]
  4. Number of deaths by suicide [ Time Frame: 6 months and 13 months ]
  5. Score in the scale C-SSRS [ Time Frame: inclusion, 6 months and 13 months ]
  6. Presence of a disorder in the MINI: characterization of the comorbidity [ Time Frame: 6 months and 13 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Written informed consent
  • Surviving a suicide attempt
  • Leaving directly the emergency department or hospitalized less than 7 days
  • Being able to be joined by telephone mobile

Exclusion Criteria:

  • under guardianship
  • Patient who are not able to provide a consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02106949


Locations
France
CHU Angers
Angers, France
CHRU de Brest
Brest, France, 29609
CHU Caen
Caen, France
CHRU Lille
Lille, France
CHU de Lyon
Lyon, France
CHU Nantes
Nantes, France
CH Quimperlé
Quimperlé, France
CHU Rennes
Rennes, France
CHU de Saint-Etienne, Hôpital Nord
Saint Etienne, France, 42055
CH St Malo
St Malo, France, 35403
CHU St Nazaire
St Nazaire, France
CHU Tours
Tours, France
CH Vannes
Vannes, France
Sponsors and Collaborators
University Hospital, Brest
Technopôle Brest-Iroise: LANESTEL SARL, 38 rue Jim Sevellec, 29200 Brest

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University Hospital, Brest
ClinicalTrials.gov Identifier: NCT02106949     History of Changes
Other Study ID Numbers: SIAM
RB 13-068 [CHRU Brest]
First Posted: April 8, 2014    Key Record Dates
Last Update Posted: March 19, 2018
Last Verified: March 2018

Keywords provided by University Hospital, Brest:
suicide attempt, SMS monitoring, recurrence, phone, prevention control, tertiary healthcare

Additional relevant MeSH terms:
Suicide
Suicide, Attempted
Self-Injurious Behavior
Behavioral Symptoms